FrontPage is India's Stock Market Social Network
Join 50,000+ Traders and Investors
forum

NEULANDLAB Share Price Discussion

Neuland Laboratories Ltd.
Sector: Pharmaceuticals and health care
... Read more
NEULANDLAB Long Term Analysts Rating
5/5 (2 Ratings)
NEULANDLAB Share Price *
476.5 -7.4 (-1.53%)
* (quote may be delayed)

Find answers to all your questions on live NEULANDLAB message board: Is NEULANDLAB buy or sell? Should I buy NEULANDLAB shares? Why are NEULANDLAB shares falling? Should I invest in NEULANDLAB stock?


You can also check NEULANDLAB share price target recommended by brokerages.

NEULANDLAB Discussion Forum


NEULAND LABS - WHILE WE CONTINUE TO SEE GROWTH IN KEY PRODUCTS, THERE IS A DAMPENING IN OUTLOOK FOR FLUOROQUINOLONES IN REGULATED MARKETS
Like
reply
Reply
@neeraj • Reputation: 1,396

Start watching NEULANDLAB for today. CMP 642-644. SL 632. Target 652-662-672. keety qty very low (50-100 max)
Like
reply
Reply (1)
Latest replies
Neeraj Puri Goswami @neeraj
Jul 3 3:44 PM

NEULANDLAB free call given at 642-643. now made high 647
@neeraj • Reputation: 1,396
Neeraj Puri G in NEULANDLAB
NEULANDLAB blasting. CMP 606-609. SL 599. Target open

NEULANDLAB was suggested at 606-609. now made high 626.70. Hope you enjoyed this call
Like
reply
Reply
@neeraj • Reputation: 1,396

NEULANDLAB blasting. CMP 606-609. SL 599. Target open
Like
reply
Reply
@newsbot • Reputation: 1,933
Like
reply
Reply
@newsbot • Reputation: 1,933
Like
reply
Reply
@newsbot • Reputation: 1,933
Like
reply
Reply
@newsbot • Reputation: 1,933
Like
reply
Reply
@newsbot • Reputation: 1,933
Like
reply
Reply
@newsbot • Reputation: 1,933
Like
reply
Reply
@newsbot • Reputation: 1,933
Like
reply
Reply
@newsbot • Reputation: 1,933
Like
reply
Reply
@newsbot • Reputation: 1,933
Like
reply
Reply
SOURCE: Data from D'Market via Quandl. Intraday data delayed 15 minutes.
DISCLAIMER: Information is provided "as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and FrontPage will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein.